Dal Poggetto John's Form 4 filing
Sonoma Pharmaceuticals, Inc. (SNOA) · filed Jul 9, 2026
- Accession no.
- 0001683168-26-005418
- Filed
- Jul 9, 2026, 8:46 PM ET
- Trade date
- Jul 9, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 derivative transaction. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dal Poggetto JohnCIK 0001791040 | Officer (Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
Referenced by the price of 1 transaction in Table II.
- F3
The RSUs were awarded and granted to Mr. Dal Poggetto for services performed.
Referenced by the price of 1 transaction in Table II.